Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -3.17% is 184% below its 5-year average of 3.75%, near the low end of its 5-year range (-3.17%–6.63%).
237.23% below its 12-month average of -0.94%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
-3.17%
RETURN ON ASSETS (ROA) AVG TTM
-0.94%
RETURN ON ASSETS (ROA) AVG 3Y
2.58%
RETURN ON ASSETS (ROA) AVG 5Y
3.75%
RETURN ON ASSETS (ROA) AVG 10Y
4.63%
RETURN ON ASSETS (ROA) AVG 15Y
6.07%
RETURN ON ASSETS (ROA) AVG 20Y
5.95%
CURRENT VS TTM AVG
-237.23%
CURRENT VS 3Y AVG
-222.99%
CURRENT VS 5Y AVG
-184.50%
CURRENT VS 10Y AVG
-168.52%
CURRENT VS 15Y AVG
-152.23%
CURRENT VS 20Y AVG
-153.29%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-161.67%
vs the sector median at left
Charles River Laboratories International, Inc.
Market Cap
$13.36B
Return on Assets (ROA)
-3.17%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
Market Cap
$13.12B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$13.68B
Return on Assets (ROA)
1.97%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$12.94B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$12.62B
Return on Assets (ROA)
8.13%
TTM Avg
5.32%
3Y Avg
4.08%
5Y Avg
2.47%
Market Cap
$14.39B
Return on Assets (ROA)
34.50%
TTM Avg
22.59%
3Y Avg
17.42%
5Y Avg
13.40%
Market Cap
$11.89B
Return on Assets (ROA)
8.33%
TTM Avg
7.48%
3Y Avg
6.38%
5Y Avg
5.99%
Market Cap
$11.32B
Return on Assets (ROA)
7.03%
TTM Avg
4.83%
3Y Avg
6.67%
5Y Avg
7.46%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | $13.36B | -3.17% | -0.94% | 2.58% | 3.75% |
| The Cooper Companies, Inc. (COO)vs › | $13.12B | 1.89% | 3.10% | 3.02% | 7.71% |
| Revvity, Inc. (RVTY)vs › | $13.68B | 1.97% | 2.19% | 1.89% | 3.83% |
| Baxter International Inc. (BAX)vs › | $12.94B | -5.37% | -3.64% | -1.62% | 0.47% |
| Penumbra, Inc. (PEN)vs › | $12.62B | 8.13% | 5.32% | 4.08% | 2.47% |
| Exelixis, Inc. (EXEL)vs › | $14.39B | 34.50% | 22.59% | 17.42% | 13.40% |
| Encompass Health Corporation (EHC)vs › | $11.89B | 8.33% | 7.48% | 6.38% | 5.99% |
| DaVita Inc. (DVA)vs › | $11.76B | 4.79% | 4.84% | 4.27% | 4.56% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 7.03% | 4.83% | 6.67% | 7.46% |
| Solventum Corporation (SOLV)vs › | $15.51B | 10.07% | 7.10% | 8.43% | 7.35% |
ROA
-3.2%
ROE
-8.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-27 | -2.02% |
| 2024-12-28 | 0.14% |
| 2023-12-31 | 5.79% |
| 2022-12-31 | 6.40% |
| 2021-12-31 | 5.57% |
| 2020-12-31 | 6.63% |
| 2019-12-31 | 5.37% |
| 2018-12-31 | 5.87% |
| 2017-12-31 | 4.21% |
| 2016-12-31 | 5.71% |
| 2015-12-31 | 7.22% |
| 2014-12-31 | 6.72% |
| 2013-12-31 | 6.25% |
| 2012-12-31 | 6.13% |
| 2011-12-31 | 7.03% |
| 2010-12-31 | -19.42% |
| 2009-12-31 | 5.19% |
| 2008-12-31 | -24.16% |
| 2007-12-31 | 5.50% |
| 2006-12-31 | -2.18% |
| 2005-12-31 | 5.59% |
| 2004-12-31 | 3.42% |
| 2003-12-31 | 10.02% |
| 2002-12-31 | 7.15% |
| 2001-12-31 | 6.20% |
| 2000-12-31 | -2.73% |
| 1999-12-31 | 4.72% |
| 1998-12-31 | 9.98% |
